Zobrazeno 1 - 10
of 215
pro vyhledávání: '"Gj, Lindeman"'
Autor:
Maria Joao Silva, Mark Rosenthal, Alice Ruth Bergin, Andrew W. Roberts, Daniel H.D. Gray, GB Mann, D Liew, Jayesh Desai, Kylie Shackleton, Anand Murugasu, GJ Lindeman, Sheau Wen Lok, François Vaillant, James R. Whittle, S-J Dawson, C Teh, Avraham Travers, Peter Sherman, Zhen Rong Siow, JE Visvader
Publikováno v:
Cancer Research. 79:PD1-06
Background: Venetoclax, a potent and selective inhibitor of the survival protein BCL-2 (recently approved in CLL and in development in other hematopoietic malignancies), has yet to be evaluated in pts with solid tumors. BCL-2 is overexpressed in ˜85
Autor:
N Lalaoui, Merino, Delphine, G Giner, F Vaillant, D Chau, L Liu, T Kratina, Pal, Bhupinder, JR Whittle, Etemadi, Nima, Berthelet, Jean, J Gräsel, C Hall, ME Ritchie, Ernst, Matthias, GK Smyth, Vaux, David, JE Visvader, GJ Lindeman, Silke, John
© 2020, The Author(s), under exclusive licence to ADMC Associazione Differenziamento e Morte Cellulare. Smac mimetics target inhibitor of apoptosis (IAP) proteins, thereby suppressing their function to facilitate tumor cell death. Here we have evalu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecf501fb6b8f40ba466b0d0b8ffb3017
Autor:
Bhupinder Pal, Gordon K. Smyth, JE Visvader, François Vaillant, Sheau Wen Lok, Göknur Giner, Emma Nolan, Kylie Shackleton, Lachlan Whitehead, GB Mann, GJ Lindeman
Publikováno v:
Cancer Research. 76:P3-11
Background: BRCA1 mutation carriers often undergo prophylactic mastectomy to minimize their risk of breast cancer. The value of targeting ovarian hormones to prevent breast tumorigenesis remains contentious and the identification of an effective and
Autor:
GJ Lindeman, E Nolan, F Vaillant, D Branstetter, B Pal, G Giner, L Whitehead, SW Lok, GB Mann, Consortium kConFab, K Rohrbach, L-Y Huang, R Soriano, GK Smyth, WC Dougall, JE Visvader
Publikováno v:
Cancer Research. 77:S2-04
Background: BRCA1 mutation carriers commonly undergo prophylactic mastectomy to reduce their risk of breast cancer. The precise role of chemoprevention with tamoxifen, which reduces the incidence of ER-positive breast cancer in the general population
Autor:
Jaring Schreuder, L Di Stefano, Yunshun Chen, Kevin H. Liu, Tom S. Weber, Jane E. Visvader, M-L Asselin-Labat, Bhupinder Pal, Anthony T. Papenfuss, François Vaillant, Dawn S. Lin, Daniel L Cameron, Antonin Serrano, Shalin H. Naik, Delphine Merino, Gordon K. Smyth, GJ Lindeman, Ton N. Schumacher
Publikováno v:
Nature Communications, Vol 10, Iss 1, Pp 1-2 (2019)
Nature Communications
Nature Communications
Primary triple negative breast cancers (TNBC) are prone to dissemination but sub-clonal relationships between tumors and resulting metastases are poorly understood. Here we use cellular barcoding of two treatment-naïve TNBC patient-derived xenograft
Autor:
Daniel H.D. Gray, Kevin H. Liu, GJ Lindeman, François Vaillant, Bhupinder Pal, Antonia N. Policheni, James R. Whittle, JE Visvader, Gordon K. Smyth, CE Caldon, Göknur Giner, K Fernandez
Publikováno v:
Cancer Research. 79:PD7-07
Background: Despite incremental advances in chemotherapy and endocrine therapy, survival outcomes for patients with ER-positive (ER+) metastatic breast cancer (MBC) remain poor. The majority of relapsing tumors exhibit deregulation of the cyclin-depe
Autor:
Louisa J. Phillipson, Matthew E. Ritchie, Lily Lee, Bhupinder Pal, François Vaillant, Gordon K. Smyth, GB Mann, Delphine Merino, Christopher J. Burns, JE Visvader, GJ Lindeman, Michael Christie, Kelsey Breslin
Publikováno v:
Cancer Research. 73:P2-09
Background: Impairment of apoptosis is a hallmark of cancer and can result in resistance to therapy. Over-expression of the pro-survival protein BCL-2 is common in breast cancer, with elevated levels found in approximately 85% of luminal tumors. Alth
Autor:
Samantha R. Oakes, Heidi N. Hilton, Lewis A. Chodosh, Melanie April Pritchard, Marie Liesse Asselin-Labat, Margaret Gardiner-Garden, Katrina Blazek, GJ Lindeman, Michael Kazlauskas, Matthew J. Naylor, Jane E. Visvader, Christopher J. Ormandy, Peter L. Pfeffer
Publikováno v:
Genes & Development. 22:581-586
Hormonal cues regulate mammary development, but the consequent transcriptional changes and cell fate decisions are largely undefined. We show that knockout of the prolactin-regulated Ets transcription factor Elf5 prevented formation of the secretory
Autor:
Matthew E. Ritchie, GJ Lindeman, Tamara Beck, Julie Sheridan, Jane E. Visvader, François Vaillant, Gordon K. Smyth, Sarah A. Best, Kenneth Liu, Kun Jiang, Ross A. Dickins
Publikováno v:
BMC Cancer
Background The molecular regulators that orchestrate stem cell renewal, proliferation and differentiation along the mammary epithelial hierarchy remain poorly understood. Here we have performed a large-scale pooled RNAi screen in primary mouse mammar
Autor:
Ross A. Dickins, Jane E. Visvader, Bhupinder Pal, Andreas Strasser, François Vaillant, Marie Liesse Asselin-Labat, Phillipe Bouillet, Delphine Merino, Sarah A. Best, Robin L. Anderson, GJ Lindeman
Publikováno v:
Oncogene. 34(30)
Evasion of cell death is fundamental to the development of cancer and its metastasis. The role of the BCL-2-mediated (intrinsic) apoptotic program in these processes remains poorly understood. Here we have investigated the relevance of the pro-apopto